Karissa Waddick
Editor | LinkedInKarissa Waddick is an editor for PharmaVoice. She most recently covered the ins and outs of workplace safety and health policy for Inside Washington Publishers, writing about federal and local COVID-19 vaccine regulations. Prior to that role, she helped build a database of need-to-know policy and business influencer profiles at National Journal. Though a Boston-area native, Karissa moved to the Washington, D.C., area to attend American University and has stayed ever since. She is an avid Red Sox fan, amateur photographer and crafting enthusiast.
123 articles by Karissa Waddick
-
Inside Bavarian Nordic’s late-stage stumbles — and drive to become a vaccine giant
Sept. 27, 2023 -
Three years after an FDA rejection, DBV sees a path for its peanut patch
Sept. 22, 2023 -
O.G. Ice-T teams up with Sanofi in horror-themed flu vax ad
Sept. 14, 2023 -
A tale of two biotechs — 2seventy, Regeneron announce C-suite shakeups
Sept. 12, 2023 -
In advocates’ ongoing push for superbug funding, ‘$6 billion is nothing’
Sept. 8, 2023 -
Pharma faces a slew of leadership shakeups
Sept. 7, 2023 -
Lawmakers are already gunning for more dramatic drug pricing reforms
Aug. 31, 2023 -
Medicare named the first 10 drugs up for negotiation. Now what?
Aug. 30, 2023 -
Are weight loss drugs a win for the global economy?
Aug. 28, 2023 -
Drug shortages: The ‘fundamental problem’ that has pharma’s top regulator ‘fired up’
Aug. 25, 2023 -
Behind Flagship Pioneering’s triumphs and tribulations
Aug. 18, 2023 -
A leading Democrat reveals how his mental health struggles shape his policy approach
Aug. 17, 2023 -
Pharma’s rare disease rush
Aug. 14, 2023 -
Why AbbVie’s former president has high hopes for this Flagship-backed biotech
Aug. 7, 2023 -
PBMs could soon feel the regulatory sting
Aug. 4, 2023 -
As Barbie breaks the box office, women’s health investment explodes
Aug. 2, 2023 -
With OTC birth control approved, access battles have just begun
July 26, 2023 -
Biogen’s layoffs are the latest in an industrywide slip
July 26, 2023 -
4 controversial measures in Congress’ pandemic preparedness bill
July 20, 2023 -
AI’s great expectations
July 19, 2023 -
Threads joins the social media fray. Here’s what it means for pharma marketers.
July 18, 2023 -
Flagship, PhRMA prioritize experience in hot summer exec changes
July 14, 2023 -
FDA’s upcoming psychedelic review looms large for a budding industry
July 12, 2023 -
A BMS exec’s journey around the world in 90 days
July 5, 2023 -
Transgender patients are rarely included in clinical trials. Can pharma fix it?
June 29, 2023